Generic Semaglutide vs Ozempic: Is It the Same Medicine?
Generic semaglutide is now launching in India, Canada, and Brazil. Is it the same as Ozempic? Here's what equivalence actually means — and what to look for.
Read moreEverything about compounding pharmacy, personalised weight management and pharmacies in the Netherlands.
Generic semaglutide is now launching in India, Canada, and Brazil. Is it the same as Ozempic? Here's what equivalence actually means — and what to look for.
Read moreOzempic costs €300+ per month in some countries and €14 in others. Here's the patent economics behind the price — and why 2026 is changing everything.
Read moreConsidering semaglutide for weight management? Here's what to expect in week 1, month 1, and beyond — from dose titration to side effects to lifestyle pairings.
Read moreCounterfeit and grey market semaglutide is a growing problem. Here's how to tell if what you're buying is the real thing — and what to do if you're not sure.
Read moreIndia's semaglutide patent expired March 20, 2026. Within 48 hours, 15 generic versions launched at ₹1,290/month — a 90% drop from Ozempic. Here's what it means for Indian patients.
Read moreA clear, non-hype explanation of what semaglutide actually does inside your body — the gut, the brain, the pancreas — and why that matters for how you take it.
Read moreThree brand names, two molecules, very different labels. Here's an honest comparison of Ozempic, Wegovy, and Mounjaro — what the differences actually mean for patients.
Read moreNausea is the most common reason people stop semaglutide in the first month. Here's a practical, evidence-based playbook for getting through the first four weeks.
Read moreGLP-1 drugs like semaglutide and tirzepatide are not for everyone. Here's an honest list of who should not take them, and why — from contraindications to caution cases.
Read moreGLP-1 drugs do a lot, but diet still matters — maybe more than you think. Here's what to eat to protect muscle, avoid nausea, and get the most out of semaglutide.
Read moreRetatrutide, an experimental triple-agonist weight loss drug, has been linked to emotional blunting and reduced romantic feelings. What does the science say?
Read moreFrom GLP-1 to dual and triple agonists: how do these molecules work in your body? The chemistry behind weight management, explained without jargon.
Read moreAn honest overview of the side effects, risks and safety data of weight management medication. What does the science say? And how do you minimise risks?
Read moreYou visit your dietitian but the weight won't budge. When is it time for medical support alongside nutritional advice? And what does it cost in 2026?
Read moreTried Weight Watchers, Noom or another diet programme without results? Discover why dieting alone often isn't enough and what medical alternatives are available.
Read moreBranded medications for weight loss cost €250-500/month and are not reimbursed in 2026. Discover the affordable alternative via compounding: from €155/month.
Read moreMedical weight loss doesn't have to be expensive. Compare the costs of every option in the Netherlands: from dietitians to compounding pharmacies. Discover the affordable alternative.
Read moreCompounding is the custom preparation of medication by a pharmacist. Discover how it works, why it's legal, and what the advantages are compared to standard branded products.
Read moreDiscover why more and more Dutch people are choosing personalised weight management programmes via compounding pharmacies. Affordable, effective and under medical supervision.
Read moreCompare compounded preparations with standard branded products. Costs, quality, dosage and safety — everything laid out for Dutch consumers.
Read moreStep-by-step explanation of the Magistra platform: from questionnaire to home delivery. How to start a personalised weight management programme in 4 steps.
Read moreHow safe are compounded preparations? An overview of Dutch and European regulation, quality controls and registration requirements for compounding pharmacies.
Read moreAn honest comparison of the costs of weight management programmes in the Netherlands. From dietitians to branded products to compounding — what does it really cost?
Read moreHow do you find a licensed compounding pharmacy in the Netherlands? What should you look for? And how does Magistra simplify the search?
Read moreCalculate your BMI and discover when a personalised weight management programme makes sense. With an explanation of BMI categories and your options in the Netherlands.
Read moreHow does Magistra protect your health data? An overview of GDPR compliance, EU hosting and the security measures that safeguard your privacy.
Read moreDiet pills vs. compounding: what's the difference? Why personalised programmes via a doctor and pharmacy are safer and more effective.
Read moreAn evidence-grounded look at the Chinese semaglutide and tirzepatide peptide trade — what's really in the vial, what independent third-party testing reveals, the legal reality, and what patients should know before relying on this supply chain.
Read moreAn evidence-grounded forecast of GLP-1 medication supply and demand through 2030. Manufacturing capacity, generic ramp, demand drivers (cardiovascular, kidney, sleep apnea, oral formulations), the role of insurance unlock, and what the 2031 OECD generic wave actually means for affordability.
Read moreWhat happens when one country has $40/month generic semaglutide and another has $1,349/month branded — until 2031? An evidence-grounded look at the legal arbitrage now opening up: who travels to India, what gets through customs, the difference between the Indian-generic gray market and the Chinese-peptide gray market, and how the trade likely evolves.
Read moreIn January 2026 the GPhC tightened the rules on how UK pharmacies can supply Wegovy, Mounjaro and other weight-loss jabs. Online questionnaire-only prescribing is no longer permitted; pharmacies must conduct a two-way consultation and independently verify BMI. Here's what changed, why, and what it means for patients seeking treatment and doctors providing it.
Read moreWe audited every UK company with 'peptide' in its name on Companies House. 98 are brand new with no track record, none of the credible ones supply GLP-1, and one woman has already died. Here's what patients need to know — and the safe alternative.
Read morePersonalised weight management, doctor-guided